Back to results
Active, not recruitingPhase 2Phase 3

Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

NCT05267535

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

ATP Clinical Research

Costa Mesa, California, United States

+36 additional locations

View on ClinicalTrials.gov
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease — TrialFind